Pharmacology, Toxicology and Pharmaceutical Science
Acute Leukemia
14%
Anticoagulant Agent
78%
Antithrombin
12%
Antivitamin K
47%
Apixaban
51%
Atrial Fibrillation
43%
Azathioprine
14%
Betrixaban
14%
Bleeding
30%
Blood Clotting Factor 10a Inhibitor
16%
Clinical Study
29%
Clotting Time
16%
Cohort Study
14%
Coronavirinae
14%
Crohn Disease
14%
D Dimer
11%
Dabigatran
100%
Dabigatran Etexilate
44%
Daboia russellii
29%
Direct Oral Anticoagulant
33%
Diseases
25%
Disseminated Intravascular Clotting
14%
Drug
24%
Drug Concentration
17%
Drug Interaction
14%
Eculizumab
17%
Edoxaban
14%
Ensure
20%
Fibrinogen
16%
Heparin
60%
Inflammation
14%
Low Molecular Weight Heparin
28%
Paroxysmal Nocturnal Hemoglobinuria
44%
Pathophysiology
17%
Pharmacodynamics
14%
Procoagulant
14%
Prothrombin
43%
Reagent
42%
Recombinant Thromboplastin
13%
Rivaroxaban
63%
Thrombin
29%
Thrombin Inhibitor
20%
Thromboembolism
41%
Thromboplastin
61%
Thrombosis
21%
Tissue Factor Pathway Inhibitor
14%
Toxic Injury
22%
Viper Venom
32%
Vitamin B12
14%
Warfarin
13%
Medicine and Dentistry
Acute Leukemia
27%
Alpha 2 Adrenergic Receptor Stimulating Agent
14%
Anticoagulation
18%
Apixaban
29%
Assay
71%
Assessment
29%
Betrixaban
14%
Biological Marker
14%
Blood
14%
Blood Stasis
35%
Cells
14%
Clonidine
14%
Coagulation
46%
Coagulopathy
14%
Combination Therapy
14%
COVID-19
29%
Dabigatran
14%
Diagnosis
31%
Disseminated Intravascular Coagulation
18%
Edoxaban
14%
Erythrocyte Concentrate
29%
Ex Vivo
14%
Heparin
39%
Heparin-Induced Thrombocytopenia
16%
Inpatient
19%
Laboratory
54%
Membrane Microparticle
29%
Microparticle
14%
Monitoring
40%
Myelodysplastic Syndrome
17%
Neoplasm
14%
Neutrophil
14%
Paroxysmal Nocturnal Hemoglobinuria
29%
Partial Thromboplastin Time
20%
Pathophysiology
20%
Patient
54%
Patient with Crohn's Disease
14%
Plasma
18%
Platelet
16%
Platelet Microparticle
14%
Procoagulant
42%
Prothrombin Time
14%
Reagent
15%
Rivaroxaban
14%
Sinus Surgery
14%
Therapeutic Procedure
33%
Thrombin
17%
Thromboplastin
26%
Thrombosis
31%
Volunteer
14%
Biochemistry, Genetics and Molecular Biology
Acquired Disorder
14%
Anticoagulation
36%
Antithrombin
22%
Atrial Fibrillation
14%
Blood Level
36%
Coagulation
58%
Coronavirinae
14%
D-Dimer
19%
Dilute Russell's Viper Venom Time
14%
Disseminated Intravascular Coagulation
14%
Dose
9%
Drug Dose Regimen
5%
Electric Potential
5%
Fibrinogen
14%
Hemostasis
45%
Heparin
11%
Hirudin
14%
Immune Response
14%
Impedance
17%
Laboratory Test
11%
Liquid
5%
Liquid Chromatography Mass Spectrometry
14%
Normal Human
14%
Partial Thromboplastin Time
43%
Platelet
29%
Platelet Count
7%
Platelet-Poor Plasma
6%
Prothrombin Time
47%
Quality Control
14%
Reticulocyte
13%
Rivaroxaban
37%
Sample
35%
Scanning Electron Microscopy
5%
Screening Test
6%
Solution and Solubility
14%
Spherocytosis
14%
Tandem Mass Spectrometry
14%
Taxonomy
14%
Thrombin
46%
Thrombin Time
31%
Thrombocyte Activation
14%
Thrombocyte Function
14%
Thromboplastin
14%
Time
29%
Tissue Factor
6%
Tissue Factor Pathway Inhibitor
14%
Viperinae
9%
Vitamin K
8%